New Antidepressant for Depression

On July 26, 2013 the FDA announced its approval of a new antidepressant medication called Fetzima (levomilnacipran extended-release capsules) for the treatment of Major Depressive Disorder (MDD) in adults.

Fetzima is a once-daily medication which can taken with out without food. It is administered in dosages ranging from 40 mg to 120 mg.

While scientists are not sure exactly how it works, it is believed that it inhibits the reuptake of two neurotransmitters called serontonin and norepinephrine, causing more of these important mood-regulating chemicals to be available in the brain.